C-Reactive Protein as a Predictor of Stem Cell Transplant Complications

Completed

• Conditions: Cancer; Leukemia; Stem Cell Transplantation

• Registration Number: NCT00179868
• Lead Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago

Brief Summary

The purpose of this study is to determine if C-Reactive Protein levels are predictive for complications post transplant.

Detailed Description

Not available

Study Timeline

• Study Start: 2003-01
• Study First Submitted: 2005-09-10
• Study First Submitted QC: 2005-09-10
• Study First Posted: 2005-09-16
• Primary Completion: 2008-02
• Study Completion: 2008-02
• Status Verified: 2025-02
• Last Update Submitted: 2025-02-04
• Last Update Posted: 2025-02-06

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

• Age 6 months to 20 years
• Patient undergoing a stem cell transplant (allogeneic, syngeneic, or autologous) at Childrens' Memorial Hospital
• IRB approved informed consent (and assent for children age 12-17)

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To determine whether quantitative c-reactive protein measurements can predict major morbidity and mortality in pediatric stem cell transplant patients.	To day +100 post transplant

Trial Locations

Locations (1)

Children's Memorial Hospital; 🇺🇸 Chicago, Illinois, United States